ArticleJournal of diabetes research2025
The Diabetic Cognitive Impairment Score for Early Screening of Cognitive Impairment in Type 2 Diabetes Patients.
Shujun Zhang, Xiaoli Shi, Shaolin Zheng, Xiaoli Liang, Fen Wang, Weijie Xu, Xuefeng Yu, Yan Yang
Abstract read
In one paragraphArticle in Journal of diabetes research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Shujun ZhangDivision of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.ORCID https://orcid.org/0000-0001-8900-5067 Xiaoli ShiDivision of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.ORCID https://orcid.org/0000-0002-1765-0013 Shaolin ZhengDivision of Endocrinology, Jingzhou Hospital Traditional Chinese Medicine, Jingzhou, Hubei Province, China.
Xiaoli LiangDivision of Endocrinology, Wenchang People's Hospital, Wenchang, Hainan Province, China.
Fen WangDivision of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Weijie XuDivision of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
Xuefeng YuDivision of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.ORCID https://orcid.org/0000-0003-3961-9321 Yan YangDivision of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.ORCID https://orcid.org/0000-0001-8146-8040 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Cognitive DysfunctionDiabetes Mellitus, Type 2tau ProteinsAgedEarly DiagnosisFemaleHumansMaleMiddle AgedNomogramsPhosphorylationRisk Factorstau Proteinscognitive impairmentDCISP-tau181T2D
Identifiers
PMID40271536
PMCPMC12017955
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390